We are live on ! Find out more
CVS icon

CVS Health

1,972 hedge funds and large institutions have $68.1B invested in CVS Health in 2020 Q4 according to their latest regulatory filings, with 277 funds opening new positions, 842 increasing their positions, 720 reducing their positions, and 94 closing their positions.

New
Increased
Maintained
Reduced
Closed

195% more first-time investments, than exits

New positions opened: 277 | Existing positions closed: 94

38% more call options, than puts

Call options by funds: $1.88B | Put options by funds: $1.36B

30% more funds holding in top 10

Funds holding in top 10: 4660 (+14)

17% more capital invested

Capital invested by funds: $58.2B → $68.1B (+$9.97B)

17% more repeat investments, than reductions

Existing positions increased: 842 | Existing positions reduced: 720

9% more funds holding

Funds holding: 1,8151,972 (+157)

0.1% less ownership

Funds ownership: 76.22%76.12% (-0.1%)

Holders
1,972
Holders Change
+157
Holders Change %
+8.65%
% of All Funds
34.9%
Holding in Top 10
60
Holding in Top 10 Change
+14
Holding in Top 10 Change %
+30.43%
% of All Funds
1.06%
New
277
Increased
842
Reduced
720
Closed
94
Calls
$1.88B
Puts
$1.36B
Net Calls
+$523M
Net Calls Change
-$123M
Name Holding Trade Value Shares
Change
Change in
Stake
CFA
1076
Carroll Financial Associates
North Carolina
$1.23M -$36.2K -557 -3%
TC
1077
TwinBeech Capital
New York
$1.22M -$216K -3,321 -16%
VFPI
1078
Vantage Financial Partners (Illinois)
Illinois
$1.21M +$13K +200 +1%
RC
1079
Roundview Capital
New Jersey
$1.21M -$7.48K -115 -0.6%
SIG
1080
Sky Investment Group
Connecticut
$1.2M -$95.3K -1,465 -8%
AFM
1081
Abbot Financial Management
Massachusetts
$1.19M -$33.8K -519 -3%
MMA
1082
Miracle Mile Advisors
California
$1.19M +$171K +2,630 +18%
PWM
1083
Perigon Wealth Management
California
$1.19M -$277K -4,259 -20%
NB
1084
Northwest Bancshares
Pennsylvania
$1.18M -$635K -9,757 -36%
BCM
1085
Bluefin Capital Management
New York
$1.18M +$1.13M +17,318 New
HCM
1086
Hodges Capital Management
Texas
$1.18M +$29.3K +450 +3%
TA
1087
TruWealth Advisors
Louisiana
$1.18M +$1.12M +17,290 New
SCA
1088
Sippican Capital Advisors
Massachusetts
$1.18M -$109K -1,675 -9%
HWA
1089
Heritage Wealth Advisors
Virginia
$1.18M +$816K +12,541 +268%
DACS
1090
Dymon Asia Capital (Singapore)
Singapore
$1.17M +$1.11M +17,125 New
WWM
1091
Wolff Wiese Magana
California
$1.17M +$1.11M +17,115 New
CFGS
1092
Concourse Financial Group Securities
Alabama
$1.17M +$79.3K +1,219 +8%
FTDI
1093
First Trust Direct Indexing
Massachusetts
$1.17M +$1.11M +17,080 New
REMPR
1094
Roof Eidam Maycock Peralta (REMP)
California
$1.17M +$16.6K +255 +2%
DWT
1095
Dorsey & Whitney Trust
South Dakota
$1.16M +$2.41K +37 +0.2%
EH
1096
Equitable Holdings
New York
$1.16M -$435K -6,694 -28%
EI
1097
Ethic Inc
New York
$1.16M +$250K +3,838 +29%
RMAM
1098
Raab & Moskowitz Asset Management
New Jersey
$1.15M +$14K +216 +1%
GAMC
1099
Garner Asset Management Corp
Texas
$1.15M +$23K +354 +2%
CIAS
1100
Capital Investment Advisory Services
North Carolina
$1.15M +$154K +2,367 +16%

CVS Hedge Fund Activity: Q4 2020 in Review

1,972 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q4 2020, worth a combined $68.1B — up 17% from $58.2B a quarter earlier.

Buyers outnumbered sellers: 277 funds opened new CVS positions and 94 closed out — a net gain of 183 holders — while 842 added to existing stakes and 720 trimmed.

The largest buyer was Capital International Investors, adding an estimated $272M. The largest seller was BlackRock, cutting an estimated $508M.

  • 1,972 institutional investors held CVS Health (CVS) as of Q4 2020, up from 1,815 in Q3 2020.
  • Funds reported $68.1B of CVS Health stock for Q4 2020, up 17% quarter-over-quarter.
  • 277 funds opened new CVS Health positions in Q4 2020 and 94 closed out, a net change of +183 holders.
  • The largest CVS Health buyer in Q4 2020 was Capital International Investors, an estimated $272M added.
  • The largest CVS Health seller in Q4 2020 was BlackRock, an estimated $508M sold.

Based on aggregated 13F filings for Q4 2020.